Insights & Discussion
Pomegranate extract could potentially benefit women's reproductive health, enhance fertility, regulate menstrual cycles, support pregnancy, and help treat polycystic ovary syndrome.
In establishing the potential benefits of pomegranate extract in women's reproductive health, a wide array of methods was employed. Primarily, these included in vitro studies, animal modeling and certain clinical trials. Analyses of the antioxidant properties of the extract were done to ascertain its effectiveness in reducing oxidative stress and consequently, improving fertility. The influence of pomegranate extract on hormonal imbalances and menstrual regulation was also studied.
Discussions on the results emphasized the potential of pomegranate extract in supporting women's reproductive health. The extract was found beneficial in enhancing fertility, regulating menstruation and supporting pregnancy. Further, it could help in polycystic ovary syndrome therapy by improving insulin sensitivity and reducing oxidative damage. Its rich nutrient composition was appreciated for potentially fostering placental development and fetal growth, thus possibly mitigating the risk of early birth. Apart from reproductive health, some studies pointed towards pomegranate extract's potential anticancer properties, primarily against breast cancer.
Discover Related Insights
Pomegranate juice extract may reduce the damage to the endometrium in Polycystic ovary syndrome through its antioxidant, anti-inflammatory, anti-fibrotic, and anti-proliferative effects.
2022 Morphologie Role of pomegranate extract in restoring endometrial androgen receptor expression, proliferation, and pinopodes in a rat model of polycystic ovary syndrome Ibrahim MAA, Sadek MT, Sharaf Eldin HEM
Experimental Study Endometrium PCOS Pomegranate
To test the possible benefits of pomegranate juice extract (PJE) on endometrial injury in Polycystic ovary syndrome (PCOS), forty adult albino rats were divided into four groups, control, PJE-treated, letrozole-treated (PCOS), and PJE & PCOS groups. The respective treatments were administered for a duration of three weeks. Serum and tissue samples were assayed for Follicle-stimulating hormone, Luteinizing hormone, testosterone, estradiol, and malondialdehyde. Uterine samples were also tested using a range of histological staining techniques and a scanning electron microscope.
In the rat model of PCOS, significant increases in certain biochemical indicators in serum samples were observed while uterine sections showed numerous alterations to the endometrium, signs of inflammation and an increase in the endometrial collagen fiber content. Additionally, there was increased expression of certain immunohistochemical staining markers and a decrease in the mean number of pinopodes observed through scanning electron microscopy. However, these various potentially harmful biochemical, histological and immunohistochemical alterations were efficiently reduced with the administration of PJE. This points towards the potential benefits of PJE in addressing and potentially reducing endometrial injury associated with PCOS.
Pomegranate polyphenols have shown strong potential in preventing and treating breast cancer through various anti-cancer effects.
2021 Molecules Pharmacological and Therapeutic Properties of Punica granatum Phytochemicals: Possible Roles in Breast Cancer Moga MA, Dimienescu OG, Bălan A, Dima L, Toma SI, Bîgiu NF, et al.
Clinical Study Breast Cancer Pomegranate
The researchers conducted a systematic review of scientific literature available on PubMed and Google Scholar, that included articles written in English over the past two decades. They focused on the original research articles examining the potential role of pomegranate and its polyphenols in breast cancer prevention and treatment. In total, they selected 28 papers for review, including both clinical and preclinical studies.
The research revealed that pomegranate polyphenols display potent anti-cancer properties through several mechanisms on breast cancer cells. These mechanisms include anti-estrogenic, anti-proliferative, anti-angiogenic, anti-inflammatory, and anti-metastatic effects. Additionally, pomegranate extracts could induce cell cycle arrest, cytotoxicity, and inhibit invasion in breast cancer cells. However, findings from two small clinical trials were contradicting. Overall, pomegranate was recognised as a promising natural strategy for managing breast cancer.
Pomegranate seed oil, rich in conjugated linolenic acid, potentially acts as a cytotoxic agent on tissue tumor cells, reducing polycystic ovary syndrome manifestations.
2021 JBRA Assisted Reproduction The effect of pomegranate seed oil on human health, especially epidemiology of polycystic ovary syndrome; a systematic review Bahmani M, Shokri S, Akhtar ZN, Abbaszadeh S, Manouchehri A
Experimental Study PCOS Pomegranate
First, data for this study was collected from several databases including the Cochran library, Medline, PubMed, SID, and Science Direct. Keyword searches incorporating phrases such as "medicinal plants", "polycystic ovary syndrome", "plant", "pomegranate extract", and "menstrual irregularities" were used to uncover relevant articles spanning from 1985 to 2021. The focus of the research was to investigate the impact of pomegranate seed oil, particularly its conjugated linolenic acid (CLN) content, on polycystic ovary syndrome, a prevalent endocrine disorder among women.
The results revealed that CLN, found abundantly in pomegranate seed oil, had been previously reported to exert a potent cytotoxic effect on tumor tissue cells within the body. This characteristic placed CLN as a potential agent in predenting cancer, lowering LDL cholesterol in the blood, reducing triacylglycerol accumulation in the liver, and importantly, mitigating the effects of polycystic ovary syndrome. Alongside this, the research also underscored the beneficial effects of conjugated linoleic acid (CLA), another group of linoleic acid isomers, in cancer growth inhibition, risk reduction of atherosclerosis, and body fat decrease.
Concentrated pomegranate juice consumption can potentially lower cardiovascular disease risk factors in women with polycystic ovary syndrome.
2020 Phytotherapy Research The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial Abedini M, Ghasemi‐Tehrani H, Tarrahi MJ, Amani R
Randomised Controlled Trial Cardiovascular Disease PCOS Pomegranate
The study used a randomized clinical approach, enrolling 44 women identified with polycystic ovary syndrome, aged 18 to 40 years and above a certain body weight index. These participants were randomly divided into two groups: one group was given concentrated pomegranate juice (CPJ), while the other served as a control. Both groups were monitored over a period of 8 weeks, with baseline measurements taken for anthropometric measures, blood pressure, and biochemical parameters set at the onset and then compared at the end of the trial.
Upon completion, the group that consumed CPJ showed reductions in blood pressure and serum triglyceride levels — a known risk factor for cardiovascular diseases. There was also an increase in the amount of high density lipoprotein-cholesterol (good cholesterol) and a decrease in the triglyceride to high-density lipoprotein-cholesterol ratio. However, an increase was observed in levels of low-density lipoprotein-cholesterol (bad cholesterol). No adverse events or complications arose from CPJ consumption during the study period.
Synbiotic pomegranate juice (containing inulin and lactobacillus) can improve insulin resistance, reduce testosterone level, and aid weight loss in women suffering from Polycystic Ovarian Syndrome.
2019 Nutrition, Metabolism and Cardiovascular Diseases Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial Esmaeilinezhad Z, Babajafari S, Sohrabi Z, Eskandari MH, Amooee S, Barati-Boldaji R
Randomised Controlled Trial Insulin Resistance Obesity PCOS
In this randomized, controlled, triple-blind, parallel trial study, patients diagnosed with Polycystic Ovarian Syndrome (92 in total) were grouped into four groups of 23. The three treatment groups received 2 litres of synbiotic pomegranate juice (SPJ), pomegranate juice (PJ), and a synbiotic beverage (SB) on a weekly basis. The control group was given a placebo beverage weekly. The primary focus of this trial was to observe any changes in insulin resistance, with secondary outcomes including fasting blood sugar, insulin sensitivity, testosterone, luteinizing hormone, follicle-stimulating hormone, body mass index, and waist and hip circumference comparisons, from baseline to the end of the trial.
After finishing the trial, analyses of the remaining 86 patients indicated noticeable improvement in insulin resistance, mainly in the SPJ and SB groups. The same groups also showed a significant increase in insulin sensitivity and an overall decrease in insulin. The SPJ and SB groups also saw significant reductions in body mass index, weight, and waist circumference. Lastly, there was a noteworthy decrease in testosterone levels within the SPJ and SB groups. However, no significant changes were found in fasting plasma glucose, luteinizing hormone, and follicle-stimulating hormone in any of the groups.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.